AD risk score for the early phases of disease based on unsupervised machine learning

Analysis of Whole-Exome Sequencing Data for Alzheimer Disease Stratified by APOE Genotype

(2019) Yiyi Ma et al.   JAMA Neurology

Plasma Markers of Inflammation Linked to Clinical Progression and Decline During Preclinical AD

(2019) Alden L. Gross et al.   Frontiers in Aging Neuroscience

Predicting progression from normal cognition to mild cognitive impairment for individuals at 5 years

(2018) Marilyn Albert et al.   BRAIN

Biomarker assessment and combination with differential covariate effects and an unknown gold standard, with an application to Alzheimer’s disease

(2018) Zheyu Wang et al.   Annals of Applied Statistics

Why has therapy development for dementia failed in the last two decades?

(2016) Serge Gauthier et al.   Alzheimers & Dementia

Relationship of medial temporal lobe atrophy, APOE genotype, and cognitive reserve in preclinical Alzheimer's disease

(2015) Anja Soldan et al.   HUMAN BRAIN MAPPING

Primary age-related tauopathy (PART): a common pathology associated with human aging

(2014) John F. Crary et al.   ACTA NEUROPATHOLOGICA

Cognitive Changes Preceding Clinical Symptom Onset of Mild Cognitive Impairment and Relationship to ApoE Genotype

(2014) Marilyn Albert et al.   Current Alzheimer Research

How to interpret a small increase in AUC with an additional risk prediction marker: decision analysis comes through

(2014) Stuart G. Baker et al.   STATISTICS IN MEDICINE

Tracking pathophysiological processes in Alzheimer's disease: an updated hypothetical model of dynamic biomarkers

(2013) Clifford R Jack et al.   LANCET NEUROLOGY

CSF biomarker changes precede symptom onset of mild cognitive impairment

(2013) A. Moghekar et al.   NEUROLOGY

The diffeomorphometry of temporal lobe structures in preclinical Alzheimer's disease

(2013) Michael I. Miller et al.   NeuroImage-Clinical

Within-subject template estimation for unbiased longitudinal image analysis

(2012) Martin Reuter et al.   NEUROIMAGE

Toward defining the preclinical stages of Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease

(2011) Reisa A. Sperling et al.   Alzheimers & Dementia

The diagnosis of dementia due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer's disease

(2011) Guy M. McKhann et al.   Alzheimers & Dementia

The diagnosis of mild cognitive impairment due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer's disease

(2011) Marilyn S. Albert et al.   Alzheimers & Dementia

An operational approach to National Institute on Aging-Alzheimer's Association criteria for preclinical Alzheimer disease

(2011) Clifford R. Jack et al.   ANNALS OF NEUROLOGY

Diagnosis-Independent Alzheimer Disease Biomarker Signature in Cognitively Normal Elderly People

(2010) Geert De Meyer   ARCHIVES OF NEUROLOGY

Cerebrospinal fluid biomarker signature in Alzheimer's disease neuroimaging initiative subjects

(2009) Leslie M. Shaw et al.   ANNALS OF NEUROLOGY